Carregant...
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long‐acting beta(2)‐agonists (LABA) for adults with asthma
BACKGROUND: Poorly controlled asthma and preventable exacerbations place a significant strain on healthcare, often requiring additional medications, hospital stays or treatment in the emergency department. Long‐acting beta(2)‐agonists (LABA) are the preferred add‐on treatment for adults with asthma...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2015
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6513433/ https://ncbi.nlm.nih.gov/pubmed/26031392 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011438.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|